These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


73 related items for PubMed ID: 4016771

  • 21. Induction of DNA-protein crosslinks by dichloromethane in a V79 cell line transfected with the murine glutathione-S-transferase theta 1 gene.
    Hu Y, Kabler SL, Tennant AH, Townsend AJ, Kligerman AD.
    Mutat Res; 2006 Sep 05; 607(2):231-9. PubMed ID: 16765633
    [Abstract] [Full Text] [Related]

  • 22. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro.
    McGown AT, Fox BW.
    Cancer Chemother Pharmacol; 1986 Sep 05; 17(3):223-6. PubMed ID: 3742706
    [Abstract] [Full Text] [Related]

  • 23. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J, McQuillan A, Aubin R, Alaoui-Jamali M, Batist G, Christodoulopoulos G, Panasci LC.
    Mutat Res; 1995 May 05; 336(3):269-78. PubMed ID: 7739615
    [Abstract] [Full Text] [Related]

  • 24. Mutagenicity of heterocyclic nitrogen mustards (ICR compounds) in cultured mammalian cells.
    O'Neill JP, Fuscoe JC, Hsie AW.
    Cancer Res; 1978 Mar 05; 38(3):506-9. PubMed ID: 626955
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 26. Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil.
    Pandya U, Srivastava SK, Singhal SS, Pal A, Awasthi S, Zimniak P, Awasthi YC, Singh SV.
    Biochem Biophys Res Commun; 2000 Nov 11; 278(1):258-62. PubMed ID: 11071881
    [Abstract] [Full Text] [Related]

  • 27. Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targets.
    Tew KD, Erickson LC, White G, Wang AL, Schein PS, Hartley-Asp B.
    Mol Pharmacol; 1983 Sep 11; 24(2):324-8. PubMed ID: 6888373
    [Abstract] [Full Text] [Related]

  • 28. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 11; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 29. Glutathione S-transferase M1 and multidrug resistance protein 1 act in synergy to protect melanoma cells from vincristine effects.
    Depeille P, Cuq P, Mary S, Passagne I, Evrard A, Cupissol D, Vian L.
    Mol Pharmacol; 2004 Apr 11; 65(4):897-905. PubMed ID: 15044619
    [Abstract] [Full Text] [Related]

  • 30. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 31. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
    Ho SB, Yan PS, Dahiya R, Neuschwander-Tetri BA, Basbaum C, Kim YS.
    J Cell Physiol; 1994 Aug 15; 160(2):213-26. PubMed ID: 7913708
    [Abstract] [Full Text] [Related]

  • 32. Increased expression of cytosolic glutathione S-transferases in drug-resistant L5178Y murine lymphoblasts: chemical selectivity and molecular mechanisms.
    Stelmack GL, Goldenberg GJ.
    Cancer Res; 1993 Aug 01; 53(15):3530-5. PubMed ID: 8101761
    [Abstract] [Full Text] [Related]

  • 33. Activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in sensitive and resistant L5178Y lymphoblasts in vitro.
    Begleiter A, Leith MK, Johnston JB.
    Cancer Res; 1994 Jan 15; 54(2):482-6. PubMed ID: 8275485
    [Abstract] [Full Text] [Related]

  • 34. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF, Waxman DJ.
    Arch Biochem Biophys; 1993 Dec 15; 307(2):369-78. PubMed ID: 8274024
    [Abstract] [Full Text] [Related]

  • 35. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
    Tsukamoto N, Chen J, Yoshida A.
    Blood Cells Mol Dis; 1998 Jun 15; 24(2):231-8. PubMed ID: 9714700
    [Abstract] [Full Text] [Related]

  • 36. Transduction of NIH 3T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase pi produces broad-range multidrug resistance.
    Doroshow JH, Metz MZ, Matsumoto L, Winters KA, Sakai M, Muramatsu M, Kane SE.
    Cancer Res; 1995 Sep 15; 55(18):4073-8. PubMed ID: 7664283
    [Abstract] [Full Text] [Related]

  • 37. Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein.
    Endresen L, Bakka A, Rugstad HE.
    Cancer Res; 1983 Jun 15; 43(6):2918-26. PubMed ID: 6850603
    [Abstract] [Full Text] [Related]

  • 38. The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues.
    Andersson BS, Mroue M, Britten RA, Murray D.
    Cancer Res; 1994 Oct 15; 54(20):5394-400. PubMed ID: 7923171
    [Abstract] [Full Text] [Related]

  • 39. POTENTIAL ANTICANCER AGENTS. IV. HETEROCYCLIC PHOSPHORAMIDE NITROGEN MUSTARDS.
    ZIMMER H, SILL AD.
    Arzneimittelforschung; 1964 Feb 15; 14():150-1. PubMed ID: 14229652
    [No Abstract] [Full Text] [Related]

  • 40. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Feb 15; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.